Aripiprazole: pharmacodynamics of a dopamine partial agonist for the treatment of schizophrenia. (Record no. 16119265)

MARC details
000 -LEADER
fixed length control field 01509 a2200433 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515015738.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200605s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0176-3679
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1055/s-2006-931485
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Gründer, G
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20060524
245 00 - TITLE STATEMENT
Title Aripiprazole: pharmacodynamics of a dopamine partial agonist for the treatment of schizophrenia.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Pharmacopsychiatry
Date of publication, distribution, etc. Feb 2006
300 ## - PHYSICAL DESCRIPTION
Extent S21-5 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antipsychotic Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aripiprazole
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cerebral Cortex
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Corpus Striatum
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dopamine Agonists
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Limbic System
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mesencephalon
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neural Pathways
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Piperazines
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Quinolones
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptors, Dopamine D2
General subdivision agonists
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Schizophrenia
General subdivision diagnosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Schizophrenic Psychology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Serotonin 5-HT2 Receptor Antagonists
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kungel, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ebrecht, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Göröcs, T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Modell, S
773 0# - HOST ITEM ENTRY
Title Pharmacopsychiatry
Related parts vol. 39 Suppl 1
-- p. S21-5
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1055/s-2006-931485">https://doi.org/10.1055/s-2006-931485</a>
Public note Available from publisher's website

No items available.